The value of serum ADA in the management and follow-up of tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 581s Year: 2002
Clinical significance of low serum isoniazid level among the patients with drug-sensitive pulmonary tuberculosis who showed delayed smear or culture conversion. Source: International Congress 2018 – New developments in tuberculosis Year: 2018
Relationship between levels of serum adenosin deaminase (ADA) and sputum smear conversion in patients with pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 425s Year: 2004
Factors affecting sputum conversion time in patients with smear positive tuberculosis Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control Year: 2007
Factors that affect sputum smear and culture conversion in patients with smear positive pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 428s Year: 2005
Evaluation of ADA activity in BAL fluid in patients with smear negative pulmonary tuberculosis Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Value of bronchoscopic specimens for the diagnosis of sputum smear negative tuberculosis in high burden multidrug resistant tuberculosis setting Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions Year: 2012
Sputum smear negative pulmonary tuberculosis (PTB) – when should the treatment be started? Source: Eur Respir J 2006; 28: Suppl. 50, 505s Year: 2006
High serum CA-125 level in active pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 415s Year: 2005
Vitamin-D supplementation in patients with new smear positive pulmonary tuberculosis (PTB) with refrence to sputum conversion Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011
Bronchoscopy as a diagnostic tool in pulmonary tuberculosis suspects with sputum smear negative status Source: Annual Congress 2007 - Tuberculosis control Year: 2007
A study to assess the magnitude and reasons of initial default among sputum smear positive pulmonary tuberculosis patients Source: Annual Congress 2010 - Tuberculosis control Year: 2010
Added value of the combination of sputum microscopy for acid fast bacilli and IP-10 and IFN-g biomarker based whole blood tests in the diagnosis of pulmonary tuberculosis Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis Year: 2009
The significance of IP-10 level in blood serum for TB diagnosis in patients with late-stage HIV infection Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019
Evaluation of lung high resolution Ct scan (HRCT) in PPD positive cases who had close contact with BK positive sputum smear patients Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013
The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Treatment outcomes of smear positive pulmonary tuberculosis cases Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005
Evaluation of new smear positive tuberculosis patients 5 years after initiation of treatment under a DOTS programme Source: Annual Congress 2010 - Tuberculosis epidemiology Year: 2010
Infectiousness of tuberculosis patients identified through spot sputum screening compared to patients identified through passive case finding-comparing sputum smear microscopy results Source: International Congress 2015 – Latent TB infection and screening Year: 2015
Risk factors and clinical outcomes of delayed smear conversion in smear positive pulmonary tuberculosis Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016